Farda R Qureshi, MD
Pediatrics · Sunnyvale
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 3
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Qureshi’s office at (408) 730-2200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Medicaid work
$41,572 in 2024
Medicaid paid $41,572 for 2,298 billed services this clinician did in 2024, up to 74 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Developmental screening | 248 | $15,335 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 187 | $7,480 |
| Screening performed and negative | 406 | $5,887 |
| Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use | 43 | $3,033 |
| Short return visit (20+ min) | 758 | $2,563 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 89 | $1,209 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 129 | $1,193 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 27 | $1,047 |
| Return visit (30+ min) | 121 | $736 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 15 | $618 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 17 | $618 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 52 | $456 |
| 2024 | 2,298 | 20 | 74 | $41,572 |
| 2023 | 5,885 | 32 | 102 | $125,949 |
| 2022 | 4,500 | 26 | 108 | $86,643 |
| 2021 | 5,830 | 28 | 121 | $115,669 |
| 2020 | 5,610 | 25 | 107 | $101,228 |
| 2019 | 8,117 | 30 | 158 | $77,011 |
| 2018 | 6,554 | 27 | 192 | $75,466 |
See the largest Medicaid services in earlier years
2023
| Developmental screening | 418 | $26,657 |
| Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use | 101 | $22,280 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 539 | $16,487 |
| Pure tone audiometry (threshold); air only | 549 | $8,511 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 229 | $8,460 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 153 | $7,496 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 203 | $7,001 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 132 | $4,480 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 150 | $3,978 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year) | 52 | $3,859 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 69 | $2,696 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 311 | $2,392 |
2022
| Developmental screening | 331 | $21,404 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 481 | $14,984 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 241 | $8,858 |
| Pure tone audiometry (threshold); air only | 450 | $7,145 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 155 | $6,878 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 185 | $5,835 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 143 | $3,675 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose | 68 | $2,720 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 311 | $2,427 |
| Short return visit (20+ min) | 890 | $2,102 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 40 | $1,560 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 39 | $1,541 |
2021
| Developmental screening | 777 | $46,506 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 534 | $15,207 |
| Pure tone audiometry (threshold); air only | 565 | $8,209 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 180 | $7,975 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 218 | $7,736 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 254 | $5,953 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 87 | $3,400 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 129 | $3,369 |
| Short return visit (20+ min) | 1,134 | $2,645 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 341 | $2,446 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 58 | $2,320 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 89 | $2,049 |
2020
| Developmental screening | 713 | $37,748 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 472 | $12,507 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 203 | $7,038 |
| Pure tone audiometry (threshold); air only | 506 | $6,661 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 297 | $6,412 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 143 | $6,095 |
| Short return visit (20+ min) | 1,154 | $5,898 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year) | 65 | $5,384 |
| Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use | 106 | $2,902 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 395 | $2,802 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 60 | $1,342 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 167 | $1,076 |
2019
| LIMITED VISUAL FIELD XM UNI/BI I&R | 808 | $13,659 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 433 | $10,610 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 441 | $9,071 |
| Pure tone audiometry (threshold); air only | 856 | $7,416 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 254 | $7,397 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 202 | $3,698 |
| Short return visit (20+ min) | 1,313 | $3,500 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year) | 50 | $3,492 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 756 | $3,401 |
| Developmental screening | 78 | $2,586 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 41 | $1,576 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 310 | $1,560 |
2018
| LIMITED VISUAL FIELD XM UNI/BI I&R | 653 | $16,167 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 376 | $10,993 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 315 | $10,598 |
| Pure tone audiometry (threshold); air only | 686 | $8,338 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 158 | $5,719 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 633 | $4,127 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 135 | $3,795 |
| Short return visit (20+ min) | 1,264 | $3,653 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year) | 64 | $3,616 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 217 | $1,438 |
| HEMOGLOBIN | 788 | $1,208 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 125 | $970 |
Money from drug and device companies
$16 in 2025
| 2025 | 1 | 1 | None | $16 |
| 2024 | 2 | 2 | None | $27 |
| 2023 | 3 | 7 | None | $98 |
| 2022 | 2 | 2 | None | $38 |
| 2020 | 2 | 2 | None | $27 |
| 2019 | 1 | 1 | None | $11 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Bexsero | $16 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2025-02-20 | Bexsero | $16 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $27
| Phadia US | Immunocap | $14 | 1 payment
|
| GlaxoSmithKline | Bexsero | $13 | 1 payment
|
2023: $98
| Cranial Technologies | Doc Band | $62 | 5 payments
|
| Merck Sharp & Dohme | Vaxelis | $20 | 1 payment
|
| Sanofi Pasteur | Beyfortus | $16 | 1 payment
|
2022: $38
| Cranial Technologies | Doc Band | $23 | 1 payment
|
| Sanofi Pasteur | Vaxelis | $15 | 1 payment
|
2020: $27
| Cranial Technologies | Doc Band | $15 | 1 payment
|
| Covis Pharma GmbH | Alvesco | $12 | 1 payment
|
2019: $11
| Sanofi Pasteur | Fluzone Quadrivalent | $11 | 1 payment
|
Professional record
- NPI
- 1285601252
- Licence
- CA 0A53700
More record details
- Sole proprietor
- Yes
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 500 E Remington Dr, Suite 15, Sunnyvale, CA, 94087
- NPI first listed
- 2006-03-08
- NPI last updated
- 2012-01-11
This is when the NPI record was last certified, not a medical board exam.